Biopsy Devices Market Size Worth $2.3 Billion by 2020 | CAGR 6.4%: Grand View Research, Inc.

SAN FRANCISCO, July 18, 2018 /PRNewswire/ --

The global biopsy devices market size is expected to reach USD 2.3 billion by 2020, according to a new report by Grand View Research, Inc., progressing at a CAGR of 6.4% during the forecast period. Growing incidence of cancer, rising geriatric population across the world, and soaring demand for less invasive biopsy procedures are some of the key trends stimulating market growth.

     (Logo: https://mma.prnewswire.com/media/661327/Grand_View_Research_Logo.jpg )

Demand for minimally invasive biopsy procedures is rising at a significant rate in the market. Different types of technologies and products such as, biopsy guiding systems, needle-based biopsy guns, and vacuum assisted devices are anticipated to witness high growth during the forecast period.

North America is likely to command a considerable revenue share in the market throughout the forecast period. On the other hand, Asia Pacific is projected to post a noteworthy CAGR during the same period.

In emerging economies, high price of biopsy devices can hinder the growth of the market. Patients in the countries are generally price sensitive and need more efficient and effective medical technologies and facilities. There are several regulatory changes coming across the world to address unmet needs of patients in these areas.

High unmet patient needs coupled with rapidly improving healthcare infrastructure in emerging countries such as India and China are poised to augment the regional market. Advent of technologically advanced and efficient products such as Vacora and Finesse Ultra Breast Biopsy System by BARD and Celero VAB device by Hologic Inc. is stoking the growth of the market. Besides this, burgeoning popularity of these devices in developed countries such as the U.S., Canada, and Japan are expected to boost the growth of the overall market during the forecast period.

Some of the key players in the biopsy devices market are Inard Inc.; Carefusion Corporation; Devicor Medical Products, Inc; DTR Medical; Hologic Inc.; C.R. Bard Inc. and Cardinal Health Inc. These companies are involved in developing and adding technologically advanced and cost effective instruments to their product portfolio.

Browse full research report with TOC on "Biopsy Devices Market Size, Share & Trends Analysis Report By Product (Needle-based Biopsy Guns, Biopsy Guidance Systems, Biopsy Forceps, Biopsy Needles), By Region, Competitive Landscape, And Segment Forecasts, 2012 - 2020" at: https://www.grandviewresearch.com/industry-analysis/biopsy-devices-industry

Further Key Findings From the Report Suggest: 

• Due to rapid technological advancements and high efficiency, biopsy guidance systems are anticipated to register sharp rise in their demand over the forecast period
• Surging demand for less invasive surgeries and disposable biopsy devices is one of the primary growth stimulants for the market
• Technologies such as vacuum assisted biopsy devices are able to facilitate easy removal of large tissue samples. Upsurge in their demand will influence the overall market positively
• The North America market was at the forefront of the market. The region is driven by various factors such as better infrastructure, patient awareness, and good healthcare facilities
• Asia Pacific is estimated to emerge as the fastest growing region in the global arena.

Browse related reports by Grand View Research: 

• Tissue Diagnostic Market - Growing prevalence of cancer coupled with growing demand for personalized medicine are anticipated to propel the growth of the tissue diagnostic market over the forecast period.
• Point of Care (PoC) Molecular Diagnostics Market - The Global point of care molecular diagnostics market was valued at USD 1.2 billion in 2015.
• In-Vitro Colorectal Cancer Screening Tests Market - The global in-vitro colorectal cancer screening tests market was valued at USD 559.3 million in 2014 and is likely to grow at a CAGR of 5.2% over the forecast period.
• Lung Cancer Diagnostics Market - The global lung cancer diagnostics market size was estimated at USD 1.63 billion in 2015

Grand View Research has segmented the global biopsy devices market based on product and region: 

• Biopsy Devices Product Outlook (Revenue USD Million, 2012 - 2020) 
  • Needle-based Biopsy Guns
    • Vacuum-assisted Biopsy (VAB) Devices
    • Fine Needle Aspiration Biopsy (FNAB) Devices
    • Core Needle Biopsy (CNB) devices
  • Biopsy Guidance Systems
    • Manual
    • Robotic
  • Biopsy Needles
    • Disposable
    • Reusable
  • Biopsy Forceps
    • General Biopsy Forceps
    • Hot Biopsy Forceps
  • Others
    • Brushes
    • Curettes
    • Punches
• Biopsy Devices Regional Outlook (Revenue USD Million, 2012 - 2020) 
  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East and Africa

Explore the BI enabled intuitive market research database, The Grand Library, by Grand View Research, Inc.

About Grand View Research 

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Contact:
Sherry James
Corporate Sales Specialist, USA
Grand View Research, Inc
Phone: +1-415-349-0058
Toll Free: 1-888-202-9519
Email: [email protected]

Web: https://www.grandviewresearch.com